11 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33803289 | Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. | 2021 Mar 9 | 1 |
2 | 33922540 | Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. | 2021 Apr 23 | 2 |
3 | 34426902 | Dimethyl fumarate prevents cytotoxicity and apoptosis mediated by oxidative stress in human adipose-derived mesenchymal stem cells. | 2021 Sep | 1 |
4 | 29928650 | The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. | 2018 Jun | 2 |
5 | 28156185 | Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. | 2017 Dec | 3 |
6 | 25009787 | Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms. | 2014 | 5 |
7 | 24076006 | Effects of fumaric acid esters on blood-brain barrier tight junction proteins. | 2013 Oct 25 | 2 |
8 | 15655414 | Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. | 2005 Feb | 1 |
9 | 15877230 | Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. | 2005 Sep | 1 |
10 | 15467770 | Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. | 2004 Oct 18 | 2 |
11 | 10376975 | Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. | 1999 Jun | 1 |